Cyagen Biosciences

Cyagen Biosciences, a provider of custom-engineered mouse and rat models with operations in the US and China, has entered into a partnership valued at RMB 1 billion (USD 139.5 million) with China-based gene therapy specialist Neurophth Biotechnology Ltd. The collaboration aims to leverage Cyagen’s professional gene therapy AI high-throughput adeno-associated…